FAT1 and neoplasm: But two mechanisms that promote tumorigenesis have been reported; one in which inactivated FAT1 acts as a tumor suppressor, resulting in aberrant Wnt/β-catenin signaling in multiple cancer types, and another in which loss of FAT1 leads to increased CDK6 expression via activation of the Hippo pathway [116,117].